Skip to main navigation Skip to search Skip to main content

CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantation

  • Niculae Ciobanu
  • , Carolyn D. Runowicz
  • , Peter H. Wiernik
  • , Timothy Strauman
  • , Carol Sheridan
  • , Robert C. Bast

Research output: Contribution to journalArticlepeer-review

Abstract

Levels of CA 125, determined in three patients with ovarian carcinoma undergoing autologous bone marrow transplantation, dropped significantly in the month after bone marrow transplantation. This decrease was linear by multiple regression analysis. The CA 125 decrease after bone marrow transplantation in patients with nonevaluable or stable disease may represent biologic response to high-dose therapy.

Original languageEnglish (US)
Pages (from-to)354-355
Number of pages2
JournalAmerican journal of obstetrics and gynecology
Volume160
Issue number2
DOIs
StatePublished - Feb 1989
Externally publishedYes

Keywords

  • CA 125
  • bone marrow transplantation
  • ovarian carcinoma

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantation'. Together they form a unique fingerprint.

Cite this